Phase II trial of radiotherapy (RT) with concurrent cisplatin (C) plus panitumumab (pmAb) for patients (pts) with high-risk, resected head and neck cancer (HNC).
Robert L. Ferris
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Amgen; Bristol-Myers Squibb
Nicole Cherie Schmitt
No relevant relationships to disclose
Dwight Earl Heron
No relevant relationships to disclose
Jonas Talmadge Johnson
No relevant relationships to disclose
Seungwon Kim
No relevant relationships to disclose
Umamaheswar Duvvuri
Honoraria - Novartis
David Andrew Clump
No relevant relationships to disclose
Jennifer Grandis
Research Funding - Bristol-Myers Squibb; Novartis
Julie E. Bauman
Research Funding - Bristol-Myers Squibb; Genentech; Lilly
William E. Gooding
No relevant relationships to disclose
Athanassios Argiris
No relevant relationships to disclose